ArticleJournal of asthma and allergy2023

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization.

Jonathan Corren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.